SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech binary events -- Ignore unavailable to you. Want to Upgrade?

To: rkrw who wrote (127)10/15/2003 12:54:41 PM
From: keokalani'nui  Read Replies (2) | Respond to of 295
 
>>Will the fda decide or ask for more time? Deadline is closing in.<<

Since they both agreed to defer the AC meeting would not the PDUFA deadline be tolled?



To: rkrw who wrote (127)10/15/2003 5:55:30 PM
From: Miljenko Zuanic  Respond to of 295
 
FDA will respond with non-approvable letter, at this time. More trials is must, imo.

Miljenko

PS: Currently short on CVTX, played short three times in last three months.



To: rkrw who wrote (127)10/23/2003 3:31:37 PM
From: tuck  Read Replies (1) | Respond to of 295
 
FDA panel to look at CVTX' Ranexa Dec 9:

Message 19428649

Cheers, Tuck


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News